Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Recent Research
K (Lysine) Acetyltransferase 8 (KAT8, also known as MOF or MYST1) is a HAT protein that is conserved among multiple species. It is a histone acetyltransferase belonging to the MYST family (Moz- Ybf2/Sas3-Sas2-Tip60) that contains a conserved acetyl- CoA-binding motif, a zinc finger domain and a chromo domain. It is reported that KAT8 is expressed in many types of tissues, including the ovary. KAT8 affects gene expression in multiple biological processes, and it implicated in several biological processes including DNA replication, DNA repair, cell cycle and tumorgenesis.
In Drosophila, KAT8 is a key component of the X chromosome dosage compensation complex, which is essential for balancing the expression of X-linked gene between male and female. It has been found that KAT8 not only maintains self-renewal and pluripotency of mouse embryonic stem cells (ESCs), but also facilitates the generation of induced pluripotent stem cells in human, suggesting KAT8 may be related to the establishment of both totipotency and pluripotent lineage in embryos. In Kat8 knockout mouse ESCs, levels of several critical transcription factors, such as Oct4, Nanog and Sox2 are significantly decreased and these genes are directly targeted by KAT8. KAT8 is also involved in metabolism by binding to mitochondrial DNAs and regulating their expression. Serious mitochondrial degeneration, high-energy consumption, as well as defective oxidative phosphorylation could be observed after Kat8 deletion in mouse cardiomyocytes, which indicates that KAT8 plays an important role in connecting epigenetics with metabolism.
Mice lacking KAT8 in oocytes are infertile with smaller ovarian size. This indicates that KAT8 is necessary for oocyte and follicle development. Increased reactive oxygen species (ROS) levels are observed in Kat8 knockout oocytes. In other words, low level of the ROS is essential for the normal oocyte and follicle development (Figure 1).Some studies have identified KAT8 as the first HAT with an essential role in mouse follicle development and female fertility.
Figure 1. Working model of how oocyte and follicle development is regulated by KAT8.
In fact, KAT8 contains a chromodomain for DNA binding and a C-terminal HAT domain for histone acetylation.It is reported that maternal histone acetyltransferase KAT8 is required for porcine preimplantation embryo development. Knockdown of KAT8 significantly reduced the blastocyst formation rate and total cell number per blastocyst. These results demonstrate that maternal KAT8 is indispensable for porcine early embryo development potentially through maintaining the proliferation of the first two lineages and genome integrity.
In addition, KAT8 acetylates histone substrates via two complexes, male-specific lethal (MSL) and non- specific-lethal (NSL). Though the NSL complex can acetylate histone H4 at lysines 5 and 8, the major histone substrate for KAT8 is histone H4 lysine 16 (H4K16). KAT8 also acetylates non-histone substrate, such as p53 at lysine 150. Acetylated p53 promotes the expression of several pro-apoptotic factors, such as PUMA and BAX. Besides, KAT8 can regulate its own activity by acetylating itself at lysine 274. Recent studies have shown that KAT8 is also associated with the SET1/MLL histone methyltransferase containing WDR5 and several other proteins in a multiprotein complex that catalyzes both histone acetylation and methylation. Additionally, KAT8-containing KANSL complex-mediated histone H4K16Ac promotes dimethylation at histone H3K4 by interacting with SET/MLL complexes.KAT8 and histone H4K16Ac regulate gene activation by cooperating with or affecting other histone modifications.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.